Skip to main content
SpringerLink
Log in
Book cover

Clinical Guide to Cardiac Autonomic Tests pp 331–356Cite as

Influence of Smoking, Alcohol, Caffeine and Recreational Drugs on Cardiac Autonomic Tests

  • Chapter

Abstract

The assessment of the autonomic nervous system is an important area of clinical cardio-neurophysiology. The individual tests are being used mainly to quantify the status of the sympathetic and parasympathetic balance in a variety of clinical conditions including a history of syncope, diabetes, cardiac failure, risk stratification after acute myocardial infarction, etc.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Grassi G, Seravalle G, Calhoun D, Bolla G. Cigarette Smoking and the adrenergic nervous system. Clin and Exper Hyperten 1992, A14: 251–260.

    Article  CAS  Google Scholar 

  2. Rang H, Dale M. Pharmacology, Churchill Livivingstone, New York 1995.

    Google Scholar 

  3. AHA Task Force. Cigarette smoking and cardiovascular disease. Circulation 1984; 70: 1114A - 1117A.

    Google Scholar 

  4. Zhu B Q, Parmley W. Haemodynamic and vascular effects of acute and passive smoking. Am Heart J 1995; 130: 1270–1275.

    Article  PubMed  CAS  Google Scholar 

  5. Klein L. Cigarette smoking, atherosclerosis and the coronary dynamic response: a unifying hypothesis. JAm Coll Cardiol 1984, 4: 972–974.

    Article  CAS  Google Scholar 

  6. Zimmerman M, McGeachie J. The effects of nicotine on aortic endothelium: a quantitative ultrasound study. Atherosclerosis1984; 63: 33–41.

    Google Scholar 

  7. Wells AJ. Passive smoking as a cause of heart disease. J Am Coll Cardiol 1994; 24: 546–554.

    Article  PubMed  CAS  Google Scholar 

  8. Debias DA, Banerjee CM, Birkhead NC, Greene CH. Effects of carbon monoxide inhalation on ventricular fibrillation. Arch Eviron Health 1976; 31: 38–42.

    Google Scholar 

  9. Turino GM, Effect of carbon monoxide toxicity: physiology and biochemistry. Circulation 1981; 63: 253–259.

    Google Scholar 

  10. Green MS, Jucha E, Luz Y. Blood Pressure in smokers and non smokers: epidemiologic findings. Am Heart J 1986; 111: 932–940.

    Article  PubMed  CAS  Google Scholar 

  11. Pickering T, Schwartz JE, James JD. Ambulatory blood pressure monitoring for evaluating the relationship between lifestyle, hypertension and cardiovascular risk, Clin Exp Pharmacol Physio 1995; 22: 226–231.

    Article  CAS  Google Scholar 

  12. Novak DJ, Victor M, The vagus and sympathetic nerve in alcoholic polyneuropathy. Arch Neurol 1974; 30: 273–284.

    Article  PubMed  CAS  Google Scholar 

  13. Guo Y, McLeod JG, Baverstock J. Pathological changes in the vagus nerve in diabetes and chronic alcoholism. J Neurol Neurosurg Psychiat 1987; 50: 1449–1453.

    Article  PubMed  CAS  Google Scholar 

  14. van de Borne P, Mark A, Montano N, Mion D, Somers V. Effects of alcohol on sympathetic activity, haemodynamics and chemoreflex sensitivity. Hypertension 1997; 29: 1278–1283.

    Article  PubMed  CAS  Google Scholar 

  15. Koskinen P, Virolainen J Kupari M. Acute alcohol intake decreases short term heart rate variability in healthy subjects. Clin Sci 1994; 87: 225–230.

    PubMed  CAS  Google Scholar 

  16. Kanel WB, Sorlie P. Hypertension in Framingham, Epidemiology and control of hypertension. Stratton, New York 1975, 553–592.

    Google Scholar 

  17. Arkwright P, Beilin LI, Rouse IL, Armstrong BK. Effects of alcohol use and other aspects of lifestyle on blood pressure levels and prevalence of hypertension in working populations. Circulation 1982; 66: 60–66.

    Article  PubMed  CAS  Google Scholar 

  18. Klatsky AL, Friedman GD, Siegeland AB, Geraard MJ. Alcohol Consumption and blood pressure. New Eng J Med 1977; 296: 1194–1200.

    Article  PubMed  CAS  Google Scholar 

  19. Braunnwald E. Heart disease, 5th Edn, Saunders, New York 1997, 1412 1414.

    Google Scholar 

  20. Adachi J, Mizoi Y. Acetaldehyde-mediated alcohol sensitivity and elevation of plasma catecholamine in man. Japan J Phar, nacol 1983; 33: 531–539.

    CAS  Google Scholar 

  21. Guaza C, Borrell. Adrenomedullary response to acute and chronic ethanol administration to rats. JBiochem Phar, naol 1983; 32: 3091–3095.

    CAS  Google Scholar 

  22. Heikkonen E, Maki T, Kontula K, Ylikhari R, Harkonen M. Physical exercise after alcohol intake: effect on plasma catecholamine and lymphocytic beta adrenergic receptors. Alcohol Clin Exp Res 1991; 15: 291–294.

    Google Scholar 

  23. Dillon J, Nolan J, Plevris J, Ewing D, Neilson J, Bouchier I. Autonomic function in cirrhosis assessed by cardiovascular reflex tests and 24 hour heart rate variability. Am J Gastroenterol 1994; 89: 1544–1547.

    PubMed  CAS  Google Scholar 

  24. Gentile S, Marmo R, Peduto A, Montella F. Autonomic neuropathy in liver cirrhosis: relationship with alcoholic aetiology and severity of disease. Ital J Gastroenterol 1984; 26: 53–58.

    Google Scholar 

  25. Dillon J, Nolan J, Thomas H, Williams BC. The correction of autonomic dysfunction in cirrhosis by captopril. J Hepatol 1997; 26: 331–335.

    Article  PubMed  CAS  Google Scholar 

  26. Battig K. Coffee, cardiovascular and behavioural effects, current research trends, Rev Environ Health 1991; 9: 53–84.

    Article  PubMed  CAS  Google Scholar 

  27. Smits P, Thien T. Coffee and the human cardiovascular system. Netherland J Med 1987; 31: 36–45.

    CAS  Google Scholar 

  28. Myers MG. Effects of caffeine on blood pressure. Arch Inter Med 1988; 148: 1189–1193.

    Article  CAS  Google Scholar 

  29. Robertson D, Frolich JC, Carr RK, Watson JT. Effects of caffeine on plasma renin activity, catecholamine and blood pressure. New Engl J Med 1978; 298: 181–186.

    Article  PubMed  CAS  Google Scholar 

  30. Robertson D, Wade D, Workman R, Woolsey R. Tolerance to the humoral and haemodynamic effects of caffeine. J Clin Invest 1981; 67: 1111–1117.

    Article  PubMed  CAS  Google Scholar 

  31. Ammon H, Biek PR, Mandelaz D, Verspohl EJ. Adaptation of blood pressure to continuous heavy coffee drinking in young volunteers. Br J Clin Pharinacol 1983; 15: 701–706.

    Article  CAS  Google Scholar 

  32. Periti M, Salvaggio A, Quaglia G, Dimarzio L. Coffee consumption and blood pressure: an Italian Study. Clin Sci 1987; 72: 443–447.

    PubMed  CAS  Google Scholar 

  33. Shirlow MJ, Berry G, Stokes G. Caffeine consumption and blood pressure: An epidemiological study. Intl J Epidein 1988; 17: 90–97.

    Article  CAS  Google Scholar 

  34. Dusseldorp M, Smits P, Thien T, Katan MB. Effects of decaffeinated vs. regular coffee on blood pressure, a 12 wk. double blind trial. Hypertension 1989; 14: 563–569.

    Article  PubMed  Google Scholar 

  35. Rosmarin PC, Applegate WB, Somes GW. Coffee consumption and blood pressure; A randomised cross over clinical trial. J Gen Intern Med 1990; 5: 211–213.

    Article  PubMed  CAS  Google Scholar 

  36. Smits P, Thien T. The cardiovascular effects of regular and decaffinated coffee. Br J Pharmacol 1985; 53: 918–922.

    Google Scholar 

  37. Izzo J, Ghosal A, Kwong K, Freeman RB. Age and prior caffeine use alter the cardiovascular and adrenomedullary responses to oral caffeine. Am J Cardiol 1983; 52: 769–773.

    Article  PubMed  CAS  Google Scholar 

  38. Smits P, Pieters G, Thien T. The role of epinephrine in the circulatory effects of coffee in man. Clin Pharm Therap 1986; 40: 431–37.

    Article  PubMed  CAS  Google Scholar 

  39. Di Marco JP, Sellers T, Berne RM, West GA. Adenosine: electrophysiological effects and therapeutic use for terminating paroxysmal SVT. Circulation 1983; 68: 1254–1263.

    Article  Google Scholar 

  40. Fredholm B, The mechanism of action of theophylline and caffeine. Acta Med Scand 1985; 217: 149–153.

    Article  PubMed  CAS  Google Scholar 

  41. Dobmeyer DJ, Stine RA, Leier CV, Greenberg R. The arrhythmogenic effects of caffeine on human beings. New Engl JMed 1983; 309: 814–816.

    Article  Google Scholar 

  42. Pirenas R, Jacobs DJ, Crow RS, Blackburn H. Coffee, tea and ventricular premature beats. J Chronic Dis 1980; 33: 67–72.

    Article  Google Scholar 

  43. Sutherland DJ, McPherson DD, Reuton KW, Spencer CA. The effect of caffeine on cardiac rate, rhythm and ventricular repolarisation. Chest 1985; 87: 319–324.

    Article  PubMed  CAS  Google Scholar 

  44. Harris L, Myers MG, Leenen FHM, Grant DM. The Cardiovascular effects of caffeine in post myocardial infarction, Circulation 1985; 72 (Suppl III): 116.

    Google Scholar 

  45. Arnesen E, Forde OH, Thelle DS. Coffee and serum cholesterol. Br Med J 1984; 288: 1960.

    Article  CAS  Google Scholar 

  46. Forde OH, Kuutsen SF, Arnesen E, Thelle DS. The Tromso Heart Study Group, Coffee consumption and serum lipid concentration in men with hypercholesterolemia; a randomised intervention study. Br Med J 1985; 290: 893–895.

    Article  CAS  Google Scholar 

  47. Jick H, Miettinen OS, Neff RK, Shapiro S, Heinonen OP. Coffee and myocardial infarction. New Engl J Med 1973; 289: 63–67.

    Article  PubMed  CAS  Google Scholar 

  48. La Croix AZ, Mead LA, Liang KY, Thomas CB. Coffee consumption and the incidence of coronary heart disease. New Engl JMed 1986; 315: 977–982.

    Article  Google Scholar 

  49. Dawber T, Kannel WB, Gordon T. Coffee and Cardiovascular disease; observation from The Framingham Study. New Engl J Med 1974; 291: 87 1874.

    Google Scholar 

  50. Mouhaffet AH, Madu EC, Satmary WA, Fraker TD. Cardiovascular complication of cocaine. Chest 1995; 107: 1426–1434.

    Article  Google Scholar 

  51. Moore K, Chiueh C, Zeldes G. Release of neurotransmitter from the brain in vivo by amphetamine, methylphenidate and cocaine. In: Ellinwood E, Kilbey M (Eds) Cocaine and other stimulants. Plenum, New York 1977, 143–160.

    Chapter  Google Scholar 

  52. Chiueh C, Kopin J. Centrally mediated release of cocaine by endogenous epinephrine and norepinephrine from the sympathoadrenal medullary system of unanaesthetised rats. J Pharmacol Exp Therap 1978; 205: 148154.

    Google Scholar 

  53. Hale SL, Alker KJ, Rezkalla SH, Eisenhauer AC, Kloner RA. Nifedipine protects the heart from the acute deleterious effects of cocaine if administered before but not after cocaine. Circulation 1991; 83: 1437–1443.

    Article  PubMed  CAS  Google Scholar 

  54. Perreault CL, Hague NL, Ransil BJ, Morgan JP. The effect of cocaine on intracellular calcium handling and myofilament calcium responsiveness in ferret myocardium. Br J Pharmacol 1990; 101: 679–685.

    Article  PubMed  CAS  Google Scholar 

  55. Smith H, Liberman HA, Broody SL, Battey LL, Donohue BC, Morris DC. Acute myocardial infarction temporally related to cocaine use. Ann Intern Med 1987; 107: 13–18.

    PubMed  Google Scholar 

  56. Isner J, Estes NM, Thompson PD, Costanzo-Nordin MR, Subramanian R, Miller G, Katsas G, Swenney K, Sturner WQ. Acute cardiac events temporarily related to cocaine abuse. New Engl JMed 1986; 315: 1438–1443.

    Article  CAS  Google Scholar 

  57. Cregler L, Mark H. Relation of acute myocardial infarction to cocaine abuse. Ain J Cardiol 1985; 56: 794.

    Article  CAS  Google Scholar 

  58. Zucker MB. Platelet function. In: Williams W, Butler E, Erslev AJ (Eds), Haematology. McGraw Hill, New York 1983, 1179.

    Google Scholar 

  59. Tonga G, Tempesta E. Platelet responsiveness and biosynthesis of thrombaxane and prostacyclin in response to in vitro cocaine treatment. Homeostasis 1985; 15: 100–107.

    Google Scholar 

  60. Chokshi S, Rongione A, Miller G. Cocaine and cardiovascular disease: the leading edge. Cardiology 1989; 111: 1–11.

    Google Scholar 

  61. Weiner R, Lockhart JT, Schwartz RG. Dilated Cardiomyopathy and cocaine abuse: report of 2 cases. Am JMed 1986; 81: 699–701.

    Google Scholar 

  62. Tazelaar HD, Karch SB, Stephens BG, Billingham ME. Cocaine and the heart. Human Pathophysiol 1987; 18: 195–199.

    Article  CAS  Google Scholar 

  63. Karch S. The pathology and aetiology of cocaine induced heart disease. Arch Pathol Lab Med 1988; 112: 225–230.

    PubMed  CAS  Google Scholar 

  64. Viramani R, Robinowitz M, Smialek JE, Smyth DF. Cardiovascular effects of cocaine: an autopsy of 40 patients. Am Heart J 1988; 115: 1068–1076.

    Article  Google Scholar 

  65. Boag F, Havard CW. Cardiac arrhythmias and myocardial ischemia related to cocaine and alcohol consumption. Post Grad Med J 1985; 61: 957–989.

    Article  Google Scholar 

  66. Ascher E, Stauffer J, Gaasch J WH. Coronary artery spasm, cardiac arrest, transient electrocardiographic Q waves and stopped myocardium in cocaine associated myocardial infarction. Am J Cardiol 1988; 61: 939–941.

    Article  PubMed  CAS  Google Scholar 

  67. Inou H, Zipes DP. Cocaine induced suprasensitivity and arrhythmogenesis. J Am Coll Cardiol 1988; 11: 867–874.

    Article  Google Scholar 

  68. Chambers H, Morris L, Tanber MG. Cocaine use and the risk for endocarditis in intravenous drug abusers. Ann Intern Med 1987; 106: 833836.

    Google Scholar 

  69. Tashkin D. Cannabis. Ann of Intern Med 1978; 89: 539–549.

    CAS  Google Scholar 

  70. Beaconsfield P, Ginsburg P, Rainsbury R. Marijuana smoking: Cardiovascular effects in man and possible mechanisms. New Engl J Med 1972; 287: 209–212.

    Article  PubMed  CAS  Google Scholar 

  71. Johnson S, Domino E. Some cardiovascular effects of marijuana smoking in normal volunteers. Clin Pharmacol Therap 1971; 12: 762–768.

    CAS  Google Scholar 

  72. Weiss J, Watanabe A, Lemberger L. Cardiovascular effects of delta 9 tetrahydrocannabinol in man. Clin Pharmacol Therap 1972; 13: 671–684.

    CAS  Google Scholar 

  73. Graham J, Li DM. Cardiovascular effects of cannabis in cats and rats. Br J Pharmacol 1973; 49: 1–10.

    Article  PubMed  CAS  Google Scholar 

  74. Domino EF, Rennick P, Pearl JH. Dose-effect relations of marijuana smoking on various physiological parameters in experienced male users. Clin Pharrnacol Therap 1974; 15: 514–520.

    CAS  Google Scholar 

  75. Benowitz N, Jones RT. Prolonged delta 9 tetrahydrocannabinol ingestion. Effects of sympathomimetic amines and autonomic blockades. Clin Pharmacol Therap 1977; 21: 336–342.

    CAS  Google Scholar 

  76. Kochar M, Hosko MJ. Electrocardiographic effects of marijuana. J Am Med Ass 1973; 225: 25–27.

    Article  CAS  Google Scholar 

  77. Hollister L, Actions of various marijuana derivatives in man. Pharinacol Rev 1971; 23: 349–357.

    CAS  Google Scholar 

  78. Perez-Reyes M, Lipton MA, Timmons MC, Wall ME, Brine DR, Davis KH. Pharmacology of orally administered delta 9 tetrahydrocannabinol. Clin Pharmacol Therap 1973; 14: 48–55.

    CAS  Google Scholar 

  79. Renault P, Schuster C, Freedman. Repeat administration of marijuana smoke to humans. Arch Gen Psychiat 1974; 31: 95–102.

    Article  PubMed  CAS  Google Scholar 

  80. Arnow W, Cassidy J. Effect of marijuana and placebo-marijuana smoking on angina pectoris. New Engl JMed 1974; 291: 65–67.

    Article  Google Scholar 

  81. Kanakis C, Pouget C, Rosen KM. The effect of delta 9 tetrahydrocannabinol on cardiac performance with and withwout beta blockade. Circulation 1976; 53: 703–707.

    Article  PubMed  CAS  Google Scholar 

  82. Shapiro BJ, Reiss S, Sullivan SF, Tashkin DP. Cardiopulmonary effects of marijuana smoking during exercise. Chest 1976; 70: 441.

    Google Scholar 

  83. Hardman H, Domino E, Seevers. General pharmacological actions of some synthetic delta tetrahydrocannabinol derivatives. Pharmacol Rev 1971; 23: 295–315.

    PubMed  CAS  Google Scholar 

  84. Cavero I, Buckley JP, Jandhyala BS. Haemodynamic and myocardial effects of delta 9 tetrahydrocannabinol in anaesthetised dogs. Eur J Pharmacol 1973; 24: 243–251.

    Article  PubMed  CAS  Google Scholar 

  85. Vollmer R, Cavero I, Ertel RJ, Solomon TA. Role of the central nervous system in the hypotension and bradycardia induced by delta 9 tetrahydrocannabinol. J Pharmac Pharmacol 1974; 26: 186–192.

    Article  CAS  Google Scholar 

  86. Benowitz N, Jones RT. Cardiovascular effects of prolong delta 9 tetrahydrocannabinol ingestion. Clin Pharmacol Therap 1975; 18: 287–297.

    CAS  Google Scholar 

  87. Neelman J, Farrell M. Fatal methadone and heroin overdoses: time trends in England and Wales. JEpiderniol Comm Health 1997; 51: 435–437.

    Article  Google Scholar 

  88. Duberstein J, Kaufman DM. A clinical study of an epidemic of heroin intoxication and heroin induced pulmonary odema. Am J Med 1971; 51: 704714.

    Google Scholar 

  89. Lipski J, Stimmel B, Donoso E. The effect of heroin and multiple drug abuse on the ECG. Am Heart J 1973; 86: 663–668.

    Article  PubMed  CAS  Google Scholar 

  90. Kapoor R, Singh S, Gandhi A. Autonomic functions and audovisual reaction time in heroin addicts. Indian J Physiol Pharmacol 1993; 37: 209–212.

    PubMed  CAS  Google Scholar 

  91. Arif A, Westermeryer I. Manual of drug and alcohol abuse. Plenum, London 1988, 131–132.

    Book  Google Scholar 

  92. Kalant H, Kalant OJ. Death in amphetamine users causes and rates. Can Med Ass 1975; 112: 299–304.

    CAS  Google Scholar 

  93. Carson P, Oldroyd K. Myocardial infarction due to amphetamine. Br Med J 1987; 294: 1525–1526.

    Article  CAS  Google Scholar 

  94. Call T, Hartneck J, Dickinson WA. Acute Cardiomyopathy secondary to intravenous amphetamine abuse. Ann Intern Med 1982; 97: 559–560.

    PubMed  CAS  Google Scholar 

  95. Smith H, Roche AH, Jaqusch MF. Cardiomyopathy associated with amphetamine administration. Am Heart J 1976; 91: 792–797.

    Article  PubMed  CAS  Google Scholar 

  96. Citron B, Halperm M, McCarron M. Necrotising angiitis associated with drug abuse, New Engl JMed 1970; 283: 1003–1011.

    Article  CAS  Google Scholar 

  97. Smit A, Wieling W, Voogel A, Koster R. Orthostatic hypotension due to suppression of vasomotor flow after amphetamine intoxication. Mayo Clin Proceed 1996; 71: 1067–1070.

    Article  CAS  Google Scholar 

  98. Vrana M, Fejfar Z, Hess L, Blazek Z. Analgosedation raises baroreflex sensitivity in acute myocardial ischemia. Cor et Vasa 1992; 34: 421–427.

    PubMed  CAS  Google Scholar 

  99. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology: Heart rate variability–Standards of measurement, physiological interpretation, and clinical use. Circulation 1996; 93: 1043–1065.

    Article  Google Scholar 

  100. Hales. Statistical Essays, Vol. 11 Haemostaticks, Innings Manby, London 1733.

    Google Scholar 

  101. Murata K, Araki S, Yokoyama K, Sata F, Yamasihta K. Autonomic neurotoxicity of alcohol assessed by heart rate variability. J Auton Nery Syst 1995, 48: 105–111.

    Google Scholar 

  102. Weise F, Krell D, Brinkhoff N. Acute alcohol ingestion reduces heart rate variability. Drug Alcohol Depend 1986; 17: 89–91.

    Article  PubMed  CAS  Google Scholar 

  103. Yokoyama A, Takagi T, Muramatsu T, Hori S. Impaired autonomic nervous system in alcoholics assessed by heart rate variation. Alcohol Clin Exp Res 1991; 15: 761–765.

    Article  Google Scholar 

  104. Weise F, Muller D, Krell D, Kielstein V. Heart rate variability in chronic alcoholics: a follow up study. Drug Alcohol Depend 1986; 17: 365–368.

    Article  PubMed  CAS  Google Scholar 

  105. Hirsch JA, Bishop B, Yook JL. Recovery of respiratory sinus arrhythmia in detoxified alcohol subjects. JAppl Physiol 1993; 74: 1816–1823.

    CAS  Google Scholar 

  106. Hayano J, Yamada M, Sakakibara Y, Fujinami T, Takata K. Short and long term effects of cigarette smoking on heart rate variability. Am J Cardiol 1990; 65: 84–88.

    Article  PubMed  CAS  Google Scholar 

  107. Niedermaier O, Smith M, Beightol M, Zukowska-Grojec Z, Goldstein G. Influence of cigarette smoking on human autonomic nervous function. Circulation 1993; 88: 562–571.

    Article  PubMed  CAS  Google Scholar 

  108. Kolodiichuk E, Arushanian EB. The effect of caffeine on the cardiac intervalogram indices depending on the ovariaSn cycle phase in women. Farinakol Toksikol 1991; 54: 28–30.

    CAS  Google Scholar 

  109. Stambler BS Morgan J, Mietus J, Moody G. Cocaine alters heart rate dynamics in conscious ferrets. Yale J Bio Med 1991; 64: 143–153.

    Google Scholar 

  110. Oriol N, Bennett F, Rigney D, Goldberger A. Cocaine effects on Neonatal Heart Rate Dynamics: preliminary findings and methodological problems. Yale J Bio Med 1993; 66: 75–84.

    CAS  Google Scholar 

  111. Regaldo M, Schechtman V, Bean X, Del Angel P. Cardiac and respiratory patterns during sleep in cocaine exposed neonates. Early Human Develop 1996; 44: 187–200.

    Article  Google Scholar 

  112. Mehta S, Finkelhor R, Anderson R, Harcar-Sevcik, Wasser T. Transient myocardial ischemia in infants prenatally exposed to cocaine. J Paed 1993; 122: 945–949.

    Article  CAS  Google Scholar 

  113. Liu W, Varner K, Characterisation of the sympathetic nerve responses to Amphetamine: role of central a-adrenergic receptors. J Cardiov Pharinacol 1996; 28: 712–722.

    Article  CAS  Google Scholar 

  114. Shindler C, Zheng JW, Tella SR, Goldberg SR. Pharmacological mechanisms in the cardiovascular effects of methamphetamine in monkeys. Pharmacol Biochern Behau 1992; 42: 791–796.

    Article  Google Scholar 

  115. Sharma U, Sheth UK. Hypotensive response to repeated doses of amphetamine and mephentermine in exp. Animals. Indian J Med Res 1977; 65: 101–104.

    PubMed  CAS  Google Scholar 

  116. Tulen J, Mulder G, Moleman P, Pepplinkhuizen L, Man In `T Veld, Van Steenis H. Effects of lorazepam on cardiac vagal tone during rest and mental stress: assessment by means of spectral analysis. Psychopharmacol 1994; 114: 81–89.

    Article  CAS  Google Scholar 

  117. Adinoff B, Mefford I, Waxman R, Linnoila M. Vagal tone decreases following intravenous diazepam. Psychiatry Res 1992; 41: 89–87.

    Article  PubMed  CAS  Google Scholar 

  118. Sharpey-Shafer EP. Effects of Respiratory acts on the circulation. In: Hamilton WF, Dow P (Eds) Handbook of Physiology. American Physiology Society, Washington 1964, Sec. 2, Vol. 3, 1875–1886.

    Google Scholar 

  119. Chida K, Takasu T, Mori N, Tokunaga K, Komatasu K. Sympathetic dysfunction mediating cardiovascular regulation in alcoholic neuropathy. Funct Neurol 1994; 2: 65–73.

    Google Scholar 

  120. Monforte R, Estruch R, Valls Sole J, Nicolas J, Villalta J, Urbano-Marquez A. Autonomic and peripheral neuropathies in patients with chronic alcoholism. Arch Neurol 1995; 52: 45–51.

    Article  PubMed  CAS  Google Scholar 

  121. Kotamaki M. Smoking induced differences in autonomic responses in military pilot candidates. Clin Autonom Res 1995; 5: 31–36.

    Article  CAS  Google Scholar 

  122. Piha SJ, Seppanen A. Attenuated Valsalva heart rate response in subjects with smoking history: possible role of autonomic dysfunction. Clin Physiol 1993; 13: 51–55.

    Article  PubMed  CAS  Google Scholar 

  123. Piha S. Cardiovascular autonomic reflexes in heavy smokers. J Autonom Nery Syst 1994; 48: 73–77.

    Article  CAS  Google Scholar 

  124. Jacobsen T, Grauburn P, Snyder R, Hansen J, Landau C, Hillis D. Effects of intranasal cocaine on sympathetic nerve discharge in humans. J Clin Inv 1997; 99: 628–634.

    Article  CAS  Google Scholar 

  125. Ravits J. AAEM minimonograph: 48: autonomic nervous system testing. Muscle and Nerve 1997; 20: 919–937.

    Article  PubMed  CAS  Google Scholar 

  126. Rechlin T, Orbes I, Weiss M, Kaschka W. Autonomic cardiac abnormalities in alcohol-dependent patients admitted to a psychiatric department. Clin Autonom Res 1996; 6: 119–122.

    Article  CAS  Google Scholar 

  127. Mancia G, Gropelli A, Rienzo D, Castiglioni P, Parati G. Smoking impairs baroreflex sensitivity in humans. Am J Physiol 1997; 273: H1555 - H1560.

    PubMed  CAS  Google Scholar 

  128. Andresen MC, Yang M, Nelson SH, Steinsland OS, Cocaine inhibits baroreflex control of blood pressure by actions at arterial baroreceptors. Am J Physiol 1990; 258:111244—H 1249.

    Google Scholar 

  129. Trouve RG, Nahas G, Latour C. Inhibition of cocaine on the baroreflex in the rat. Proc Soc Exp Biol Med 1992; 201: 215–218.

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. Azad V. Ghuran
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marek Malik
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Cardiological Sciences, St. George’s Hospital Medical School, London, UK

    Marek Malik

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Ghuran, A.V., Malik, M. (1998). Influence of Smoking, Alcohol, Caffeine and Recreational Drugs on Cardiac Autonomic Tests. In: Malik, M. (eds) Clinical Guide to Cardiac Autonomic Tests. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-1057-2_13

Download citation

  • DOI: https://doi.org/10.1007/978-94-017-1057-2_13

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-90-481-5071-7

  • Online ISBN: 978-94-017-1057-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation